CAE, Inc. (CAE) Tops Q4 EPS by 12c, Beats on Revenues

CAE, Inc. (NYSE: CAE) reported Q4 EPS of $0.37, $0.12 better than the analyst estimate of $0.25. Revenue for the quarter came in at $780.7 million versus the consensus estimate of $611.18 million.

• Q4 revenue up 6% to $780.7 million and annual revenue up 5% to $2.8 billion
• Q4 EPS from continuing operations of $0.37, up from $0.25 (up 19% from $0.31 before specific items(1)) in prior year
• Annual EPS from continuing operations of $1.29 ($1.11 adjusted*), up from $0.93 (up 8% from $1.03 before specific items) in prior year
• Record $3.9 billion annual order intake and record $7.8 billion order backlog(2)
• Annual free cash flow(3) of $288.9 million for 97% adjusted* cash conversion(4)
• Return on Capital Employed(5) of 14.4% (12.3% adjusted*) up from 11.2% last year

*Adjusted before U.S. tax reform impact and net gains on strategic transactions relating to AACE and ZFTC.

“CAE’s training strategy is proving successful as evidenced by our strong performance in the fourth quarter and fiscal year 2018 and our delivery on our growth outlook across all segments. I am especially pleased with our increased momentum to be the recognized global training partner of choice, as underscored by a record $3.9 billion annual order intake and $7.8 billion backlog,” said Marc Parent, CAE’s President and Chief Executive Officer. “We grew earnings per share by 8% this year and increased return on capital to 12.3% on higher training demand and the deployment of accretive growth capital. In Civil, we grew segment operating income by 12% and booked a record $2.3 billion in orders, and in Defence, we grew segment operating income by 6% and booked a record $1.4 billion in orders. In Healthcare, we resumed growth with the launch of innovative products and a broader market reach. Our core markets benefit from strong fundamentals and secular tailwinds, and as we look to the year ahead, we expect CAE to exceed the underlying rate of growth in these markets.”

For earnings history and earnings-related data on CAE, Inc. (CAE) click here.

You May Also Be Interested In

• Bristol-Myers Squibb (BMY) stock slips despite earnings beat
• Central Securities (CET) Releases Report to Stockholders
• CEMEX, S.A.B. de C.V. (CX) Tops Q1 EPS by 5c